IRDOpus Genetics, Inc.

$346M

FY 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$20M

Net Income

-$25M

EPS (Diluted)

$-5.28

Cash Flow

Operating Cash Flow

-$7M

Free Cash Flow

-$7M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$18M

Total Liabilities

$31M

Stockholders' Equity

-$13M

Cash & Equivalents

$16M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$20M	-$4M	-376.2%
Net Income	-$25M	-$6M	-299.1%

IRD FY 2020 Earnings — Opus Genetics, Inc. Revenue & Financial Results | Market Cap Arena